Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2006121385PMID 17554146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.

  2007cited by this paper
• Vascular calcification in dialysis patients.

  2007cited by this paper
• Mortality risk among hemodialysis patients receiving different vitamin D analogs.

  2006cited by this paper
• Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.

  2006cited by this paper
• Regulation of Fibroblast Growth Factor-23 Signaling by Klotho*

  2006cited by this paper
• Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.

  2006cited by this paper
• Pathogenic role of Fgf23 in Hyp mice.

  2006cited by this paper
• Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

  2006cited by this paper
• Premature aging‐like phenotype in fibroblast growth factor 23 null mice is a vitamin D‐mediated process

  2006cited by this paper
• Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals.

  2006cited by this paper
• Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders

  2005cited by this paper
• Absence of Intraepidermal Glycosyltransferase ppGalNac-T3 Expression in Familial Tumoral Calcinosis

  2005cited by this paper
• Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia.

  2005cited by this paper
• Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders

  2005cited by this paper
• Reversibility of Calcitriol‐Induced Medial Artery Calcification in Rats With Intact Renal Function

  2005cited by this paper
• Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3

  2005cited by this paper
• Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.

  2005cited by this paper
• An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

  2005cited by this paper
• Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone.

  2005cited by this paper
• Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

  2005cited by this paper
• A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.

  2005cited by this paper
• Vitamin D and calcium deficits predispose for multiple chronic diseases

  2005cited by this paper
• Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

  2004cited by this paper
• Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

  2004cited by this paper
• Determinants of progressive vascular calcification in haemodialysis patients.

  2004cited by this paper
• Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.

  2004cited by this paper
• Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

  2004cited by this paper
• Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

  2004cited by this paper
• Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.

  2003cited by this paper
• Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

  2003cited by this paper
• Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

  2003cited by this paper
• Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.

  2003cited by this paper
• Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis

  2003cited by this paper
• Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

  2003cited by this paper
• clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

  2002cited by this paper
• Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

  2002cited by this paper
• Overexpression of Phex in Osteoblasts Fails to Rescue the Hyp Mouse Phenotype*

  2002cited by this paper
• Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers

  2001cited by this paper
• Whole-mount procedures for simultaneous visualization of nerves, neurons, cartilage and bone.

  1999cited by this paper
• Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study

  1998cited by this paper
• 1,25-Dihydroxyvitamin D3 Increases In Vitro Vascular Calcification by Modulating Secretion of Endogenous Parathyroid Hormone–Related Peptide

  1998cited by this paper
• 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide.

  1998cited by this paper
• Induction of Aortic and Coronary Athero-arteriosclerosis in Rats Fed a Hypervitaminosis D, Cholesterol-Containing Diet 1

  1971cited by this paper

• Klotho-gonadal hormone crosstalk in male and female reproduction.

  2025cites this paper
• A role for sirtuin 1 in FGF23 activation following β-glycerophosphate treatment

  2024cites this paper
• The prognostic value of serum α-klotho in age-related diseases among the US population: A prospective population-based cohort study.

  2024cites this paper
• Non-Classical Effects of FGF23: Molecular and Clinical Features

  2024cites this paper
• Relationships of serum FGF23 and α-klotho with atherosclerosis in patients with type 2 diabetes mellitus

  2024cites this paper
• Vascular Calcification: Molecular Networking, Pathological Implications and Translational Opportunities

  2024cites this paper
• Risk factors and implications associated with ultrasound‐diagnosed nephrocalcinosis in cats with chronic kidney disease

  2024cites this paper
• Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level

  2023cites this paper
• Phosphate Toxicity and Vascular Calcification in Chronic Kidney Disease: A Closer Look Utilizing Transmission Electron Microscopy.

  2023cites this paper
• Urinary phosphate is associated with cardiovascular disease incidence

  2023cites this paper
• Fine‐tuning osteoclastogenesis: An insight into the cellular and molecular regulation of osteoclastogenesis

  2023cites this paper
• Cartilage tissues regulate systemic aging via ectonucleotide pyrophosphatase/phosphodiesterase 1 in mice

  2023cites this paper
• Dietary Contributions to Metabolic Acidosis.

  2022cites this paper
• Pathogenesis of FGF23-Related Hypophosphatemic Diseases Including X-linked Hypophosphatemia

  2022cites this paper
• Extracellular Phosphate, Inflammation and Cytotoxicity.

  2022cites this paper
• Fibroblast Growth Factor-23 in Pre-Dialysis Chronic Kidney Disease Patients and its Correlation with Carotid Artery Calcification

  2022cites this paper
• Klotho Ameliorates Vascular Calcification via Promoting Autophagy

  2022cites this paper
• Identification of core genes and pathways between geriatric multimorbidity and renal insufficiency: potential therapeutic agents discovered using bioinformatics analysis

  2022cites this paper
• Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice

  2022cites this paper
• Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice S

  2022cites this paper
• Structural and Functional Changes in Aging Kidneys

  2022cites this paper
• Inorganic phosphate‐induced cytotoxicity

  2021cites this paper
• Extrarenal expression of α-klotho, the kidney related longevity gene, in Heterocephalus glaber, the long living Naked Mole Rat

  2021cites this paper
• Klotho and calciprotein particles as therapeutic targets against accelerated ageing

  2021cites this paper
• Regulation of FGF23: Beyond Bone

  2021cites this paper
• Regulation of phosphate in health and disease

  2021cites this paper
• Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease

  2021cites this paper
• Shedding of Klotho: Functional Implications in Chronic Kidney Disease and Associated Vascular Disease

  2021cites this paper
• Risk factors for abdominal aortic calcifications in chronic hemodialysis patients

  2021cites this paper
• Association of Serum Phosphate with Low Handgrip Strength in Patients with Advanced Chronic Kidney Disease

  2021cites this paper
• Aging and FGF23-klotho system.

  2021cites this paper
• High Dietary Phosphate Exacerbates and Acts Independently of Low Autophagy Activity in Pathological Cardiac Remodeling and Dysfunction

  2021cites this paper
• High consumption of ultra-processed food may double the risk of subclinical coronary atherosclerosis: the Aragon Workers’ Health Study (AWHS)

  2020cites this paper
• High-phosphorus diets reduce aortic lesions and cardiomyocyte size and modify lipid metabolism in Ldl receptor knockout mice

  2020cites this paper
• Phosphate as a Pathogen of Arteriosclerosis and Aging

  2020cites this paper
• Small molecule FGF23 inhibitors increase serum phosphate and improve skeletal abnormalities in Hyp mice

  2020cites this paper
• Vitamin D-mitochondria cross-talk could modulate the signalling pathway involved in hypertension development: a translational integrative overview

  2020cites this paper
• Vitamin D-mitochondria cross-talk could modulate the signaling pathway involved in hypertension development: a translational integrative overview.

  2020cites this paper
• All You Can Feed: Some Comments on Production of Mouse Diets Used in Biomedical Research with Special Emphasis on Non-Alcoholic Fatty Liver Disease Research

  2020cites this paper
• How metabolic acidosis and kidney disease may accelerate the aging process

  2020cites this paper
• PTH Regulation by the Klotho/FGF23 Axis in CKD

  2020cites this paper
• Electrochemical biosensor based on pyruvate oxidase immobilized AuNRs@Cu2O-NDs as electroactive probes loaded poly (diallyldimethylammonium chloride) functionalized graphene for the detection of phosphate

  2020cites this paper
• Research Models for Studying Vascular Calcification

  2020cites this paper
• Biomarkers of vascular calcification in serum.

  2020cites this paper
• Elevated serum magnesium lowers calcification propensity in Memo1-deficient mice

  2020cites this paper
• Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease.

  2020cites this paper
• Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting.

  2020cites this paper
• Klotho: A Major Shareholder in Vascular Aging Enterprises

  2019cites this paper
• Targeted EDTA Chelation Therapy with Albumin Nanoparticles to Reverse Arterial Calcification and Restore Vascular Health in Chronic Kidney Disease

  2019cites this paper
• αKlotho–FGF23 interactions and their role in kidney disease: a molecular insight

  2019cites this paper
• Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study

  2019cites this paper
• Cardiovascular Disease in Chronic Kidney Disease

  2019cites this paper
• FGF23 at the crossroads of phosphate, iron economy and erythropoiesis

  2019cites this paper
• PKC regulates the production of fibroblast growth factor 23 (FGF23)

  2019cites this paper
• Cyclin‐dependent kinase Pho85p and its cyclins are involved in replicative lifespan through multiple pathways in yeast

  2019cites this paper
• Aging, metabolic acidosis and renal failure: Interactive accelerating processes.

  2019cites this paper
• The roles of magnesium in the mineral metabolism of biological apatite for the treatment of arthritis inspired by the deer antler

  2019cites this paper
• PTH, vitamin D, and the FGF‐23–klotho axis and heart: Going beyond the confines of nephrology

  2018cites this paper
• Clinical relevance of aortic stiffness in end-stage renal disease and diabetes: implication for hypertension management

  2018cites this paper
• The Klotho proteins in health and disease

  2018cites this paper
• Mechanisms and Regulation of Intestinal Phosphate Absorption.

  2018cites this paper
• Renal Memo1 Differentially Regulates the Expression of Vitamin D-Dependent Distal Renal Tubular Calcium Transporters

  2018cites this paper
• Disorders and Mechanisms of Ectopic Calcification

  2018cites this paper
• The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.

  2018cites this paper
• The Body-wide Transcriptome Landscape of Disease Models

  2018cites this paper
• Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease.

  2018cites this paper
• The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor.

  2018cites this paper
• Edinburgh Research Explorer New insights into NPP1 function

  2018cites this paper
• Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease.

  2018cites this paper
• The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function

  2018cites this paper
• Serum Phosphate Is Associated With Fracture Risk: The Rotterdam Study and MrOS

  2017cites this paper
• A rare cause of persistent hyperphosphatemia

  2017cites this paper
• Ironing out the cross talk between FGF23 and inflammation.

  2017cites this paper
• Understanding the Pathophysiology of Nephrocalcinosis

  2017cites this paper
• Membrane ion Channels and Receptors in Animal lifespan Modulation

  2017cites this paper
• Associations between Phosphorus Intake and Mortality

  2017cites this paper
• Clinical and Preclinical Evidence of the Skeletal and Vascular Adverse Health Effects of High Dietary Phosphorus

  2017cites this paper
• Delineating the mechanisms underlying rare disorders of ectopic calcification to reveal novel therapeutic strategies

  2017cites this paper
• Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase

  2017cites this paper
• Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.

  2017cites this paper
• The FGF23 and Klotho system beyond mineral metabolism

  2017cites this paper
• Mechanisms and Clinical Implications of Vascular Calcifications in Chronic Kidney Disease

  2017cites this paper
• DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition

  2016cites this paper
• Mitochondrial reactive oxygen species, endoplasmic reticulum stress and phosphate toxicity in impairment of pancreatic cells

  2016cites this paper
• Relationships Of Dietary Protein And Phosphorus With Protein Energy Wasting In Hemodialysis Patients

  2016cites this paper
• The Effects of Lithium on FGF 23 Die Wirkung von Lithium auf FGF 23 Inaugural

  2016cites this paper
• Modelos animales de calcificación vascular: vitamina E y magnesio como estrategias terapéuticas

  2016cites this paper
• Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes.

  2016cites this paper
• Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway

  2016cites this paper
• Vitamin D Nutrient-Gene Interactions and Healthful Aging

  2016cites this paper
• Kidney Ischemia and Reperfusion Injury - Field of Glory or Warterloo for Erythropoietin?

  2016cites this paper
• Recent Advances in Fibro-blast Growth Factor-23 Functions

  2016cites this paper
• Phosphate Toxicity in CKD: The Killer among Us.

  2016cites this paper
• Fibroblast growth factor receptor 4: the missing link between chronic kidney disease and FGF23-induced left ventricular hypertrophy?

  2016cites this paper
• Phosphate-a poison for humans?

  2016cites this paper
• Inflammation regulates fibroblast growth factor 23 production

  2016cites this paper
• Immunosuppression in IgA nephropathy: how certain are we?

  2016cites this paper
• The association of the Klotho polymorphism rs9536314 with parameters of calcium-phosphate metabolism in patients on long-term hemodialysis

  2016cites this paper
• Update on FGF23 and Klotho signaling.

  2016cites this paper
• Effectiveness and safety of a 6-month treatment with paricalcitol in patients on hemodialysis with secondary hyperparathyroidism.

  2016cites this paper